Freke M. Kloosterboer

Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia

W. A. Erik Marijt, Mirjam H.M. Heemskerk, Freke M. Kloosterboer et al. · Proceedings of the National Academy of Sciences · 2003 · 404 citations · Full text

UTY gene codes for an HLA-B60–restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T-cell recognition

Mario H. J. Vogt, Els Goulmy, Freke M. Kloosterboer et al. · Blood · 2000 · 148 citations

Multiple myeloma–reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR) gene

Cornelis A.M. van Bergen, Michel G.D. Kester, Inge Jedema et al. · Blood · 2007 · 86 citations

Identification of the angiogenic endothelial-cell growth factor-1/thymidine phosphorylase as a potential target for immunotherapy of cancer

Elisabeth H. Slager, M. Willy Honders, Edith D. van der Meijden et al. · Blood · 2006 · 65 citations

Direct cloning of leukemia-reactive T cells from patients treated with donor lymphocyte infusion shows a relative dominance of hematopoiesis-restricted minor histocompatibility antigen HA-1 and HA-2 specific T cells

Freke M. Kloosterboer, Simone A.P. van Luxemburg-Heijs, RA van Soest et al. · Leukemia · 2004 · 63 citations

Histocompatibility, Cell Therapy, Transplantation +11